Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for
the fourth quarter and full year of fiscal 2009 on Monday, August 10,
2009, and will hold a conference call on Tuesday, August 11, 2009 at
9:00 a.m. Eastern time to discuss these results. Robert E. Conway, Chief
Executive Officer, and Michael Carruthers, Chief Financial Officer, will
lead the call.
|
Conference Call Information
|
|
Date:
|
|
Tuesday, August 11, 2009
|
|
Time:
|
|
9:00 a.m. Eastern time
|
|
Toll-Free:
|
|
888-726-2459
|
|
Toll:
|
|
913-312-0977
|
|
Pass Code:
|
|
6778402
|
|
Webcast:
|
|
www.arraybiopharma.com
|
|
|
|
|
A replay of the call will be available as a webcast on www.arraybiopharma.com
and by phone for one week by dialing toll-free (888) 203-1112 or (719)
457-0820. The access code is 6778402.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory and
metabolic diseases. Our proprietary drug development pipeline includes
clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at large market opportunities.
In addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across a
broad range of therapeutic areas. For more information on Array, please
go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
